Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients

International Journal of Cancer

Volumn 79, Issue 2, 1998, Pages 147-152

  Levesque, Michael A ^a   Katsaros, Dionyssios ^b   Yu, He ^c   Giai, Maurizia ^b   Genta, Franco ^b   Roagna, Riccardo ^b   Ponzone, Riccardo ^b   Massobrio, Marco ^b   Sismondi, Piero ^b   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TURIN   (Italy)

^c Diagnostic Systems Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FEMALE; FOLLOW UP; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOASSAY; LYMPH NODE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; TUMOR VOLUME;

EID: 17144472315     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980417)79:2<147::AID-IJC9>3.0.CO;2-T     Document Type: Article

References (26)

1. ALLRED, D.C., CLARK, G.M., ELLEDGE, R., FUQUA, S.A.W., BROWN, R.W., CHAMNESS, G.C., OSBORNE, C.K. and MCGUIRE, W.L., Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J. nat. Cancer Inst., 85, 200-206 (1993).
2. ALTMAN, D.G., LAUSEN, B., SAUERBREI, W. and SCHUMACHER, M., Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J. nat. Cancer Inst., 86, 829-834 (1994).
3. BLOOM, H.J.G. and RICHARDSON, W.W., Histological grading and prognosis in breast cancer. Brit. J. Cancer, 11, 359-377 (1957).
4. BORG, A., LENNERSTRAND, J., STENMARK-ASKMALM, M., FERNO, M., BRISFORS, A., OHRVIK, A., STAL, O., KILLANDER, D., LANE, D. and BRUNDELL, J., Prognostic significance of p53 overexpression in primary breast cancer: a novel luminometric immunoassay applicable on steroid receptor cytosols. Brit. J. Cancer, 71, 1013-1017 (1995).
5. CHARPIN, C., GARCIA, S., BOUVIER, C., ANDRAC, L., DE VICTOR, B., LAVAUT, M.-N., ALLASIA, C., BONNIER, P. and PIANA, L., Quantitative immunocytochemical assays on frozen sections of p53: correlation to the follow-up of patients with breast carcinomas. Amer. J. clin. Pathol., 106, 640-646 (1996).
6. CHRISTOPOULOS, T.K. and DIAMANDIS, E.P., Enzymatically-amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem., 64, 342-346 (1992).
7. CUNNINGHAM, J.M., INGLE, J.N., JUNG, S.H., CHA, S.S., WOLD, L.E., FARR, G., WITZIG, T.E., KROOK, J.E., WEIAND, H.S. and KOVACH, J.S., p53 gene expression in node-positive breast cancer: relationship to DNA ploidy and prognosis. J. nat. Cancer Inst., 86, 1871-1873 (1994).
8. DE WITTE, H.H., KOEKENS, J.A., LENNERSTRAND, J., SMID, M., LOOK, M.P., KLIJN, J.G.M., BENRAAD, T.J. and BERNS, E.M.J.J., Prognostic significance of TP53 accumulation in human primary breast cancer: comparison between a rapid quantitative immunoussay and SSCP analysis. Int. J. Cancer, 69, 125-130 (1996).
9. HASSAPOGLIDOU, S., DIAMANDIS, E.P. and SUTHERLAND, D.J.A., Quantification of p53 protein in tumour cell lines, breast tissue extracts and serum with time-resolved immunofluorometry. Oncogene, 8, 1501-1509 (1993).
10. HOLLSTEIN, M., SIDRANSKY, D., VOGELSTEIN, B. and HARRIS, C.C., p53 mutations in human cancers. Science, 253, 49-53 (1991).
11. HOPTON, D.S., THOROGOOD, J., CLAYDEN, A. and MACKINNON, D., Observer variation in histological grading of breast cancer. Europ. J. surg. Oncol., 15, 21-23 (1989).
12. ISOLA, J., VISAKORPI, T., HOLLI, K. and KALLIONIEMI, O.-P., Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J. nat. Cancer Inst., 84, 1109-1114 (1992).
13. LEVESQUE, M.A., CLARK, G. M., YU, H. and DIAMANDIS, E.P., Immunofluorometric analysis of p53 protein and prostate-specific antigen in breast tumours and their association with other prognostic indicators. Brit. J. Cancer, 72, 720-727 (1995a).
14. LEVESQUE, M.A., D'COSTA, M., ANGELOPOULOU, K. and DIAMANDIS, E.P., Time-resolved immunoassay of p53 protein. Clin. Chem., 41, 1720-1729 (1995b).
15. LEVESQUE, M.A., D'COSTA, M., DIAMANDIS, E.P. and TADROSS, L., Compari- son of immunofluorometry and immunohistochemistry for the detection of p53 protein in lung cancer. Amer. J. clin. Pathol., 108, 184-190 (1997).
16. LEVINE, A.J., p53, the cellular gatekeeper for growth and division. Cell, 88, 323-331 (1997).
17. LIPPONEN, P., JI, H., AALTOMAA, S., SYRJANEN, S. and SYRJANEN, K., p53 protein expression in breast cancer as related to histopathological characteristics and prognosis. Int. J. Cancer, 55, 51-56 (1993).
18. PIETILAINEN, T., LIPPONEN, P., AALTOMAA, S., ESKELINEN, M., KOSMA, V.-L. and SYRJANEN, K., Expression of p53 protein has no prognostic value in breast cancer. J. Pathol., 177, 225-232 (1995).
19. ROSEN, P.P., LESSER, M.L., ARROYO, C.D., CRANOR, M., BORGEN, P. and NORTON, L., p53 in node-negative breast carcinoma: an immunohistochemical study of epidemiologic risk factors, histologic features, and prognosis. J. clin. Oncol., 13, 821-830 (1995).
20. SCHOENFELD, D.A. and RICHTER, J.R., Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics, 38, 163-170 (1982).
21. SESHADRI, R., LEONG, A.S.-Y., MCCAUL, K., FIRGAIRA, F.A., SETLUR, V. and HORSFALL, D.J., Relationship between p53 gene abnormalities and other tumour characteristics in breast-cancer prognosis. Int. J. Cancer, 69, 135-141 (1996).
22. SILVESTRINI, R., BENINI, E., DAIDONE, M.G., VENERONI, S., BORACCHI, P., CAPPELLETTI, V., DI FRONZO, G. and VERONESI, U., p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J. nat. Cancer Inst., 85, 965-970 (1993).
23. SPIESSL, B., BEAHRS, O.H., HERMANEK, P., MUTTER, R.V.P., SCHEIBE, O., SOBIN, L.H. and WAGNER, G., TNM atlas, 3rd ed., pp. 307, Springer-Verlag, Berlin (1989).
24. THOR, A.D., MOORE, D.H., EDGERTON, S.M., KAWASAKI, E.S., REIHSAUS, E., LYNCH, H.T., MARCUS, J.N., SCHWARTZ, L., CHEN, L.-C., MAYALL, B.H. and SMITH, H.S., Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J. nat. Cancer Inst., 84, 845-855 (1992).
25. THORPE, S.M., Steroid receptors in breast cancer: sources of interlaboratory variation in dextran-charcoal assays. Breast Cancer Res. Treat., 9, 175-189 (1987).
26. ZAMBETTI, G.P. and LEVINE, A.J., A comparison of the biological activities of wild-type and mutant p53. FASEB J., 7, 855-865 (1993).